Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, [electronic resource]
Producer: 20200414Description: 1396-1404 p. digitalISSN:- 1525-1438
- Adult
- Aged
- Aged, 80 and over
- BRCA2 Protein -- genetics
- Female
- Germ-Line Mutation
- Humans
- Indoles -- adverse effects
- Middle Aged
- Neoplasm Grading
- Organoplatinum Compounds -- pharmacology
- Ovarian Neoplasms -- drug therapy
- Poly(ADP-ribose) Polymerase Inhibitors -- adverse effects
- Ubiquitin-Protein Ligases -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.